The results of this study provide evidence that in Chinese paediatric patients with T1DM, insulin glargine provides glycaemic control consistent with that observed in previous studies in Europe and the US, and may be associated with a numerically lower incidence rate of hypoglycaemia compared with NPH insulin. This evidence concerns the gene INS and type 1 diabetes mellitus.